Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers.

Biotechnology

Pharmaceutical

Therapeutics

Sequoia Sciences

Sequoia Sciences' headquarters in Saint Louis, MO, United States

Kevin B. Bacon

Jim Spellmeyer

Mark O’Neil-Johnson

Eric Cunningham

Jennifer L. Harris

William C. Rusnack

Joseph P. Conran

George Paz

Michael J. Mertz

Scott J. Hultgren

Thomas M. Hooton

Brian R. Salmo

Brian L. Clevinger

James P. Bick Jr.

Michael Holmes

Stephen M. Notestine

The Clinical and Analytical Development team at Sequoia Sciences is responsible for overseeing the clinical trials, analytical testing, and manufacturing processes essential for developing new medicines. They ensure the efficacy, safety, and quality of pharmaceuticals designed to treat bacterial infections and cancers by combining expertise in clinical development, analytical chemistry, and process development.

Clinical and Analytical Development

The Leadership Team at Sequoia Sciences is responsible for strategic decision-making and guiding the company's research and development efforts. Comprising vice presidents from process development, clinical development, and analytical chemistry, this team drives collaboration across departments to ensure the efficient progression of innovative therapies targeting bacterial infections and cancers from concept to market. Their expertise and oversight play a crucial role in aligning scientific goals with business objectives, fostering a culture of excellence and compliance within the organization.

Leadership Team

Sequoia Sciences

Org chart

Board & advisors

Teams

Clinical and Analytical Development

Leadership Team

Offices

Sequoia Sciences

Org chart

Board & advisors

Teams

Clinical and Analytical Development

Leadership Team

Offices

Related companies